| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $33.2M | -24.3% |
| Cost of Revenue | $19.9M | -40.1% |
| Gross Profit | $11.8M | +10.4% |
| R&D Expense | $6.8M | -45.3% |
| SG&A Expense | $17.4M | -67.9% |
| Operating Income | -$29.4M | +49.1% |
| Pre-tax Income | -$33.5M | +44.9% |
| Income Tax | $2K | +0.0% |
| Net Income | -$28.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.2M | -27.0% |
| Short-term Investments | $1.4M | -95.7% |
| Accounts Receivable | $3.7M | -27.5% |
| Inventory | $10.2M | -7.8% |
| Current Assets | $27.8M | -57.4% |
| Total Assets | $31.3M | -60.0% |
| Current Liabilities | $19.9M | -43.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$24.7M | +46.5% |
| Capital Expenditures | $161K | -82.7% |
| Investing Cash Flow | $45.8M | +8.0% |
| Financing Cash Flow | -$24.9M | — |
| Free Cash Flow | -$24.8M | +47.2% |
| +54.0% |
| EPS (Basic) | -$59.03 | -8981.5% |
| EPS (Diluted) | -$59.03 | -8981.5% |
| Long-term Debt |
| $14.4M |
| -63.9% |
| Total Liabilities | $26.1M | -47.6% |
| Stockholders' Equity | $5.2M | -81.7% |